Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 12, 1999, Pages 2835-2842

  Yu, Jian ^a   Castagnoli Jr , Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; FUNCTIONAL GROUP; NEUROTOXIN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATTLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME KINETICS; ENZYME SUBSTRATE; LIVER MITOCHONDRION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BINDING SITES; CATTLE; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MONOAMINE OXIDASE; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0033381791     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00225-4     Document Type: Article

References (31)

1. McEwen C.M. Jr., Sasaki G., Jones D.C. Biochemistry. 8:1969;3952.
2. Strolin Benedetti M., Dorstert P. Adv. Drug Res. 23:1992;65.
3. Kuhn, D. M.; Murphy, D. L.; Youdim, M. B. H. In Structure and Function of Amine Oxidases; Mondov, B., Ed.; CRC Press Inc.: Boca Raton, FL, 1985; Chapter 22, pp 231-248.
4. Green A.R., Mitchell B., Tordoff A., Youdim M.B.H. Br. J. Pharmacol. 60:1977;343.
5. Chiba K., Trevor A., Castagnoli N. Jr. Biochem. Biophys. Res. Commun. 120:1984;574.
6. Salach J.I., Singer T.P., Castagnoli N. Jr., Trevor A. Biochem. Biophys. Res. Commun. 125:1984;831.
7. Fritz R. R.; Abell C. W.; Patel N.T., Gessner W., Brossi A. FEBS Lett. 186:1985;224.
8. Youngster S.K., Makeoun K.A., Jin Y.-Z., Ramsay R.R., Heikkila R.E., Singer T.P. J. Neurochem. 53:1989;1837.
9. Langston J.W., Irwin I., Langston E.B., Forno L.S. Science. 225:1984;1480.
10. Heikkila R.E., Hess A., Duvoisin R.C. Science. 224:1984;1451.
11. Gessner W., Brossi A., Shen R.-S., Fritz R.R., Abell C.W. Helv. Chim. Acta. 67:1984;2037.
12. Markey S.P., Johannessen J.N., Chiueh C.C., Burn R.S., Herkenham M.A. Nature. 311:1984;464.
13. Nimker S.K., Anderson A.H., Rimodi J.M., Stanton M., Castagnoli K.P., Mabic S., Wang Y.-X., Castagnoli N. Jr. Chem. Res. Toxicol. 9:1996;1013.
14. Palmer S.L., Mabic S., Castagnoli N. Jr. J. Med. Chem. 40:1997;1982.
15. Wang Y.-X., Castagnoli N. Jr. J. Med. Chem. 38:1995;1904.
16. Zhao Z.Y., Dalvie D., Naiman; Castagnoli K.P., Castagnoli N. Jr. J. Med. Chem. 35:1992;4473.
17. Youngster S.K., Sonsalla P.K., Sieber B.-A., Heikkila R.E. J. Pharmacol. Exp. Ther. 249:1989;820.
18. Youngster S.K., Sonsalla P.K., Heikkila R.E. J. Neurochem. 48:1987;929.
19. Youngster S.K., Nicklas W.J., Heikkila R.E. J. Pharmacol. Exp. Ther. 249:1989;829.
20. Anderson, A. H. Ph.D. dissertation, Virginia Polytechnic Institute and State University, 1997, p 86.
21. Yu, J.; Castagnoli, N., Jr. Bioorg. Med. Chem., in press.
22. Herrmann, J. L.; Schlessinger, R. H. J.C.S. Chem. Commun. 1973, 711.
23. Hibi S., Okamoto Y., Tagami K., Numata H., Kobayashi N., Shinoda M., Kawahara T., Harada K., Miyamoto K., Yamatsu J. Med. Chem. 38:1996;3148.
24. Ratcliffe R., Rodehorst R. J. Org. Chem. 35:1970;4000.
25. Jones, R. A. Pyrroles Part One; Wiley and Sons, Inc: New York, 1990; Vol. 48, pp 296-302.
26. Stetter H., Krassett J. Heterocyclic Chem. 14:1977;573.
27. Kruse C.G., Bouw J.P., Van Hes R., Vande Kuilen A., den Hartog J.A. J. Heterocycles. 26:1987;3145.
28. Hirano S., Hiyama T., Fujita S., Kawaguti T., Hayashi Y., Nozaki H. Tetrahedron. 30:1974;2633.
29. Pitts, S. M.; Markey, S. P.; Murphy, D. L.; Weisz, A. In MPTP - A Neurotoxin Producing a Parkinsonian Syndrome; Markey, S. P. I.; Castagnoli, N., Jr.; Trevor, A. J.; Kopin, I. J., Eds.; Academic Press: New York, 1986; pp 703-716.
30. Salach J.I., Weyler W. Methods Enzymol. 142:1987;627.
31. Tipton K.F., Singer T.P. J. Neurochem. 61:1993;1191.